ADRA1A基因编码α1A-肾上腺素受体(α1A-adrenergic receptor),属于G蛋白偶联受体(GPCR)超家族中的肾上腺素受体家族。这个基因家族包括α1(ADRA1A、ADRA1B、ADRA1D)、α2(ADRA2A、ADRA2B、ADRA2C)和β(ADRB1、ADRB2、ADRB3)亚型,它们共同通过结合儿茶酚胺(如肾上腺素和去甲肾上腺素)调节心血管、神经和代谢功能。ADRA1A主要分布在血管平滑肌、心脏、前列腺和中枢神经系统,通过激活Gq蛋白信号通路引起血管收缩、血压升高以及前列腺平滑肌收缩。该受体在维持血压稳态和应激反应中起关键作用。突变可能导致受体功能异常,如某些错义突变与原发性高血压、良性前列腺增生(BPH)和心力衰竭相关。ADRA1A过表达可能增加血管阻力导致高血压,并加重前列腺症状;而表达降低则可能引起低血压或影响交感神经系统的正常调节。药物如α1-阻滞剂(如坦索罗辛)通过选择性抑制ADRA1A来治疗高血压和BPH。此外,ADRA1A在中枢神经系统的表达与焦虑和应激行为有关,其调控异常可能影响精神疾病。该基因的遗传变异还与个体对降压药的反应差异相关。研究ADRA1A有助于开发针对心血管和泌尿系统疾病的靶向疗法。
Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. They activate mitogenic responses and regulate growth and proliferation of many cells. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This gene encodes alpha-1A-adrenergic receptor. Alternative splicing of this gene generates four transcript variants, which encode four different isoforms with distinct C-termini but having similar ligand binding properties. [provided by RefSeq, Jul 2008]
α-1肾上腺素受体(α-1-ARS)是G蛋白偶联受体超家族的成员。他们激活促有丝分裂反应,调节多种细胞的生长和增殖。有3α-1-AR亚型:阿尔法-1A,-1B和-1D,所有这些都通过的Gq / 11家族G蛋白和不同亚型的信号表明活化的不同的模式。这个基因编码的α-1A肾上腺素受体。这个基因的可变剪接产生四个转录变异体,其编码具有不同的C-末端,但具有相似的配体结合性质四个不同的同种型。 [由RefSeq的,2008年7月提供]
ADRA1A基因(以及对应的蛋白质)的细胞分布位置:
ADRA1A基因的本体(GO)信息:
名称 |
---|
4020 Calcium signaling pathway [PATH:hsa04020] |
4022 cGMP - PKG signaling pathway [PATH:hsa04022] |
4152 AMPK signaling pathway [PATH:hsa04152] |
4080 Neuroactive ligand-receptor interaction [PATH:hsa04080] |
4261 Adrenergic signaling in cardiomyocytes [PATH:hsa04261] |
4270 Vascular smooth muscle contraction [PATH:hsa04270] |
4970 Salivary secretion [PATH:hsa04970] |
名称 |
---|
Adrenoceptors |
Amine ligand-binding receptors |
Class A/1 (Rhodopsin-like receptors) |
G alpha (12/13) signalling events |
G alpha (q) signalling events |
Gastrin-CREB signalling pathway via PKC and MAPK |
GPCR downstream signaling |
GPCR ligand binding |
Signal Transduction |
Signaling by GPCR |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Diabetes Mellitus, Experimental | 0.2 | 2 | 0 | CTD_human_RGD |
Liver Cirrhosis | 0.12 | 1 | 0 | CTD_human |
Ventricular Remodeling | 0.12 | 1 | 0 | CTD_human |
Hypertensive disease | 0.103646576 | 15 | 1 | BeFree_GAD_LHGDN_RGD |
Bladder neck obstruction | 0.08 | 1 | 0 | RGD |
Polycystic Ovary Syndrome | 0.08 | 1 | 0 | RGD |
Hypotension | 0.08 | 1 | 0 | RGD |
Urinary Incontinence | 0.08 | 1 | 0 | RGD |
Memory Disorders | 0.08 | 1 | 0 | RGD |
Hyperalgesia | 0.08 | 1 | 0 | RGD |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。